Daphne Lelieveld
Utrecht University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Daphne Lelieveld.
Journal of Controlled Release | 2012
Markus de Raad; Erik A. Teunissen; Daphne Lelieveld; David A. Egan; Enrico Mastrobattista
High-content screening (HCS) uses high-capacity automated fluorescence imaging for the quantitative analysis of single cells and cell populations. Here, we developed an HCS assay for rapid screening of non-viral gene delivery systems as exemplified by the screening of a small library of peptide-based transfectants. These peptides were simultaneously screened for transfection efficiency, cytotoxicity, induction of cell permeability and the capacity to transfect non-dividing cells. We demonstrated that HCS is a valuable extension to the already existing screening methods for the in vitro evaluation of non-viral gene delivery systems with the added value that multiple parameters can be screened in parallel thereby obtaining more information from a single screening event, which will accelerate the development of novel gene delivery systems.
Scientific Reports | 2015
Ingrid T. G. W. Bijsmans; Chiara Guercini; José M. Ramos Pittol; Wienand A. Omta; Alexandra Milona; Daphne Lelieveld; David A. Egan; Roberto Pellicciari; Antimo Gioiello; Saskia W.C. van Mil
The Farnesoid X receptor (FXR) regulates bile salt, glucose and cholesterol homeostasis by binding to DNA response elements, thereby activating gene expression (direct transactivation). FXR also inhibits the immune response via tethering to NF-κB (tethering transrepression). FXR activation therefore has therapeutic potential for liver and intestinal inflammatory diseases. We aim to identify and develop gene-selective FXR modulators, which repress inflammation, but do not interfere with its metabolic capacity. In a high-throughput reporter-based screen, mometasone furoate (MF) was identified as a compound that reduced NF-κB reporter activity in an FXR-dependent manner. MF reduced mRNA expression of pro-inflammatory cytokines, and induction of direct FXR target genes in HepG2-GFP-FXR cells and intestinal organoids was minor. Computational studies disclosed three putative binding modes of the compound within the ligand binding domain of the receptor. Interestingly, mutation of W469A residue within the FXR ligand binding domain abrogated the decrease in NF-κB activity. Finally, we show that MF-bound FXR inhibits NF-κB subunit p65 recruitment to the DNA of pro-inflammatory genes CXCL2 and IL8. Although MF is not suitable as selective anti-inflammatory FXR ligand due to nanomolar affinity for the glucocorticoid receptor, we show that separation between metabolic and anti-inflammatory functions of FXR can be achieved.
Antimicrobial Agents and Chemotherapy | 2016
Rachel Ulferts; S. Matthijn de Boer; Lonneke van der Linden; Lisa Bauer; Hey Rhyoung Lyoo; María Jesús Maté; Julie Lichière; Bruno Canard; Daphne Lelieveld; Wienand A. Omta; David A. Egan; Bruno Coutard; Frank J. M. van Kuppeveld
ABSTRACT Enteroviruses (EVs) represent many important pathogens of humans. Unfortunately, no antiviral compounds currently exist to treat infections with these viruses. We screened the Prestwick Chemical Library, a library of approved drugs, for inhibitors of coxsackievirus B3, identified pirlindole as a potent novel inhibitor, and confirmed the inhibitory action of dibucaine, zuclopenthixol, fluoxetine, and formoterol. Upon testing of viruses of several EV species, we found that dibucaine and pirlindole inhibited EV-B and EV-D and that dibucaine also inhibited EV-A, but none of them inhibited EV-C or rhinoviruses (RVs). In contrast, formoterol inhibited all enteroviruses and rhinoviruses tested. All compounds acted through the inhibition of genome replication. Mutations in the coding sequence of the coxsackievirus B3 (CV-B3) 2C protein conferred resistance to dibucaine, pirlindole, and zuclopenthixol but not formoterol, suggesting that 2C is the target for this set of compounds. Importantly, dibucaine bound to CV-B3 protein 2C in vitro, whereas binding to a 2C protein carrying the resistance mutations was reduced, providing an explanation for how resistance is acquired.
Scientific Data | 2015
André F. Maia; Marvin E. Tanenbaum; Matilde Galli; Daphne Lelieveld; David A. Egan; Reto Gassmann; Claudio E. Sunkel; Sander van den Heuvel; René H. Medema
Kinesins are a superfamily of microtubule-based molecular motors that perform various transport needs and have essential roles in cell division. Among these, the kinesin-5 family has been shown to play a major role in the formation and maintenance of the bipolar mitotic spindle. Moreover, recent work suggests that kinesin-5 motors may have additional roles. In contrast to most model organisms, the sole kinesin-5 gene in Caenorhabditis elegans, bmk-1, is not required for successful mitosis and animals lacking bmk-1 are viable and fertile. To gain insight into factors that may act redundantly with BMK-1 in spindle assembly and to identify possible additional cellular pathways involving BMK-1, we performed a synthetic lethal screen using the bmk-1 deletion allele ok391. We successfully knocked down 82% of the C. elegans genome using RNAi and assayed viability in bmk-1(ok391) and wild type strains using an automated high-throughput approach based on fluorescence microscopy. The dataset includes a final list of 37 synthetic lethal interactions whose further study is likely to provide insight into kinesin-5 function.
Chromosoma | 2017
Roy G.H.P. van Heesbeen; Jonne A. Raaijmakers; Marvin E. Tanenbaum; Vincentius A. Halim; Daphne Lelieveld; Cor Lieftink; Albert J. R. Heck; David A. Egan; René H. Medema
Inhibition of the microtubule (MT) motor protein Eg5 results in a mitotic arrest due to the formation of monopolar spindles, making Eg5 an attractive target for anti-cancer therapies. However, Eg5-independent pathways for bipolar spindle formation exist, which might promote resistance to treatment with Eg5 inhibitors. To identify essential components for Eg5-independent bipolar spindle formation, we performed a genome-wide siRNA screen in Eg5-independent cells (EICs). We find that the kinase Aurora A and two kinesins, MCAK and Kif18b, are essential for bipolar spindle assembly in EICs and in cells with reduced Eg5 activity. Aurora A promotes bipolar spindle assembly by phosphorylating Kif15, hereby promoting Kif15 localization to the spindle. In turn, MCAK and Kif18b promote bipolar spindle assembly by destabilizing the astral MTs. One attractive way to interpret our data is that, in the absence of MCAK and Kif18b, excessive astral MTs generate inward pushing forces on centrosomes at the cortex that inhibit centrosome separation. Together, these data suggest a novel function for astral MTs in force generation on spindle poles and how proteins involved in regulating microtubule length can contribute to bipolar spindle assembly.
Journal of Biomolecular Screening | 2014
Roy Baas; Daphne Lelieveld; Hetty A. A. M. van Teeffelen; Philip Lijnzaad; Bas Castelijns; F. M. van Schaik; Michiel Vermeulen; David A. Egan; H. Th. Marc Timmers; Petra de Graaf
Posttranslational modifications of histones play an important role in the regulation of gene expression and chromatin structure in eukaryotes. The balance between chromatin factors depositing (writers) and removing (erasers) histone marks regulates the steady-state levels of chromatin modifications. Here we describe a novel microscopy-based screening method to identify proteins that regulate histone modification levels in a high-throughput fashion. We named our method CROSS, for Chromatin Regulation Ontology SiRNA Screening. CROSS is based on an siRNA library targeting the expression of 529 proteins involved in chromatin regulation. As a proof of principle, we used CROSS to identify chromatin factors involved in histone H3 methylation on either lysine-4 or lysine-27. Furthermore, we show that CROSS can be used to identify chromatin factors that affect growth in cancer cell lines. Taken together, CROSS is a powerful method to identify the writers and erasers of novel and known chromatin marks and facilitates the identification of drugs targeting epigenetic modifications.
The Journal of Neuroscience | 2017
Eljo Y. van Battum; Marieke G. Verhagen; Vamshidhar R. Vangoor; Yuki Fujita; Alwin A.H.A. Derijck; Eoghan O'Duibhir; Giuliano Giuliani; Thijs de Gunst; Youri Adolfs; Daphne Lelieveld; David A. Egan; Roel Q.J. Schaapveld; Toshihide Yamashita; R. Jeroen Pasterkamp
During embryonic development, axons extend over long distances to establish functional connections. In contrast, axon regeneration in the adult mammalian CNS is limited in part by a reduced intrinsic capacity for axon growth. Therefore, insight into the intrinsic control of axon growth may provide new avenues for enhancing CNS regeneration. Here, we performed one of the first miRNome-wide functional miRNA screens to identify miRNAs with robust effects on axon growth. High-content screening identified miR-135a and miR-135b as potent stimulators of axon growth and cortical neuron migration in vitro and in vivo in male and female mice. Intriguingly, both of these developmental effects of miR-135s relied in part on silencing of Krüppel-like factor 4 (KLF4), a well known intrinsic inhibitor of axon growth and regeneration. These results prompted us to test the effect of miR-135s on axon regeneration after injury. Our results show that intravitreal application of miR-135s facilitates retinal ganglion cell (RGC) axon regeneration after optic nerve injury in adult mice in part by repressing KLF4. In contrast, depletion of miR-135s further reduced RGC axon regeneration. Together, these data identify a novel neuronal role for miR-135s and the miR-135–KLF4 pathway and highlight the potential of miRNAs as tools for enhancing CNS axon regeneration. SIGNIFICANCE STATEMENT Axon regeneration in the adult mammalian CNS is limited in part by a reduced intrinsic capacity for axon growth. Therefore, insight into the intrinsic control of axon growth may provide new avenues for enhancing regeneration. By performing an miRNome-wide functional screen, our studies identify miR-135s as stimulators of axon growth and neuron migration and show that intravitreal application of these miRNAs facilitates CNS axon regeneration after nerve injury in adult mice. Intriguingly, these developmental and regeneration-promoting effects rely in part on silencing of Krüppel-like factor 4 (KLF4), a well known intrinsic inhibitor of axon regeneration. Our data identify a novel neuronal role for the miR-135–KLF4 pathway and support the idea that miRNAs can be used for enhancing CNS axon regeneration.
Cell | 2018
Norman Sachs; Joep de Ligt; Oded Kopper; Ewa Gogola; Gergana Bounova; Fleur Weeber; Anjali Vanita Balgobind; Karin Wind; Ana Gracanin; Harry Begthel; Jeroen Korving; Ruben van Boxtel; Alexandra A. Duarte; Daphne Lelieveld; Arne van Hoeck; Robert Frans Ernst; Francis Blokzijl; Isaac J. Nijman; Marlous Hoogstraat; Marieke van der Ven; David A. Egan; Vittoria Zinzalla; Jürgen Moll; Sylvia F. Boj; Emile E. Voest; Lodewyk F. A. Wessels; Paul Joannes van Diest; Sven Rottenberg; Robert G.J. Vries; Edwin Cuppen
Assay and Drug Development Technologies | 2016
Wienand A. Omta; Roy G.H.P. van Heesbeen; Romina J. Pagliero; Lieke M van der Velden; Daphne Lelieveld; Mehdi Nellen; Maik Kramer; Marley Yeong; Amir Saeidi; René H. Medema; Marco R. Spruit; Sjaak Brinkkemper; Judith Klumperman; David A. Egan
Assay and Drug Development Technologies | 2016
Romina J. Pagliero; Diego S. D'Astolfo; Daphne Lelieveld; Riyona D. Pratiwi; Sonja Aits; Marja Jäättelä; Nathaniel I. Martin; Judith Klumperman; David A. Egan